Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Surgery
Erschienen in: Indian Journal of Surgery 3/2021

10.02.2020 | Original Article

Surgery for Gastric Cancer: State of the Art

verfasst von: Manish S. Bhandare, Vikram Chaudhari, Shailesh V. Shrikhande

Erschienen in: Indian Journal of Surgery | Sonderheft 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Surgery remains the undisputed mainstay in the management of gastric cancer, and advances in chemotherapy and radiation have improved outcomes in patients with resectable disease. A multidisciplinary approach, with active coordination across specialties dealing with management of gastric cancers provides improved quality of care and outcomes. Radical gastrectomy involves complete removal of tumor with adequate margins and appropriate lymph node dissection. Spleen preserving D2 lymphadenectomy is the present standard of care for all resectable tumors except few early tumors (T1a lesions) where endoscopic or local resections are deemed suitable. Perioperative or adjuvant chemotherapy should be offered to all patients with resectable tumor, having advanced T stage or node-positive disease. In patients with advanced tumors with invasion of adjacent organs, multivisceral resections can be offered selectively in the presence of good performance status and response to chemotherapy, which can lead to improvement in overall survival. The role of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy needs to be evaluated in patients with limited peritoneal disease.
Literatur
1.
Dikshit RP, Mathur G, Mhatre S, Yeole BB (2011) Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol 32(1):3–11CrossRef
2.
Sharma A, Radhakrishnan V (2011) Gastric cancer in India. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol. 32(1):12–16CrossRef
3.
4.
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20PubMedCrossRef
5.
Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, Lee JI, Shin DB, Ji J, Chen JS, Lim Y, Ha S, Bang YJ, CLASSIC trial investigators (2014) Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 15(12):1389–1396PubMedCrossRef
6.
Shrikhande SV, Sirohi B, Barreto SG, Chacko RT, Parikh PM, Pautu J et al (2014) Indian Council of Medical Research consensus document for the management of gastric cancer. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol 35(4):239–243CrossRef
7.
Shinohara T, Ohyama S, Yamaguchi T, Muto T, Kohno A, Kato Y et al (2005) Clinical value of multidetector row computed tomography in detecting lymph node metastasis of early gastric cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 31(7):743–748
8.
Puli SR, Reddy JBK, Bechtold ML, Antillon MR, Ibdah JA (2008) How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review. World J Gastroenterol: WJG 14(25):4011–4019PubMedPubMedCentralCrossRef
9.
D’Ugo DM, Pende V, Persiani R, Rausei S, Picciocchi A (2003) Laparoscopic staging of gastric cancer: an overview. J Am Coll Surg 196(6):965–974PubMedCrossRef
10.
Cardona K, Zhou Q, Gönen M, Shah MA, Strong VE, Brennan MF, Coit DG (2013) Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Ann Surg Oncol 20(2):548–554PubMedCrossRef
11.
Irino T, Sano T, Hiki N, Ohashi M, Nunobe S, Kumagai K, Ida S, Yamaguchi T (2017) Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan. Surg Endosc 29
12.
Huang J, Luo H, Zhou C, Zhan J, Rao X, Zhao G, Zhu Z (2017) Yield of staging laparoscopy for incurable factors in Chinese patients with advanced gastric cancer. J Laparoendosc Adv Surg Tech A 26
13.
Machairas N, Charalampoudis P, Molmenti EP, Kykalos S, Tsaparas P, Stamopoulos P, Sotiropoulos GC (2017) The value of staging laparoscopy in gastric cancer. Ann Gastroenterol 30(3):287–294PubMedPubMedCentral
14.
Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H et al (2003) The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 6(3):142–145
15.
Bagaria B, Sood S, Sharma R, Lalwani S (2013) Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). Cancer Biol Med 10(3):148–157PubMedPubMedCentral
16.
17.
Hopkins S, Yang GY (2011) FDG PET imaging in the staging and management of gastric cancer. J Gastrointest Oncol 2(1):39–44PubMedPubMedCentral
18.
Washington K (2010) 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 17(12):3077–3079PubMedCrossRef
19.
Uedo N, Iishi H, Tatsuta M, Ishihara R, Higashino K, Takeuchi Y et al (2006) Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 9(2):88–92
20.
Morita S, Katai H, Saka M, Fukagawa T, Sano T, Sasako M (2008) Outcome of pylorus-preserving gastrectomy for early gastric cancer. Br J Surg 95(9):1131–1135PubMedCrossRef
21.
Mochiki E, Kamiyama Y, Aihara R, Nakabayashi T, Asao T, Kuwano H (2005) Laparoscopic assisted distal gastrectomy for early gastric cancer: five years’ experience. Surgery. 137(3):317–322PubMedCrossRef
22.
Hiki N, Nunobe S, Kubota T, Jiang X (2013) Function-preserving gastrectomy for early gastric cancer. Ann Surg Oncol 20(8):2683–2692PubMedCrossRef
23.
Kwon YH, Heo J, Lee HS, Cho CM, Jeon SW (2014) Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther 39(6):609–618PubMedCrossRef
24.
Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730PubMedCrossRef
25.
Lee J, Lim DH, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK (2012) Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol Off J Am Soc Clin Oncol 30(3):268–273CrossRef
26.
Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R, Torri V (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente). Ann Oncol 11(7):837–835PubMedCrossRef
27.
Bang Y-J, Kim Y-W, Yang H-K, Chung HC, Park Y-K, Lee KH et al (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379(9813):315–321PubMedCrossRef
28.
Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, ACTS-GC Group (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357(18):1810–1820PubMedCrossRef
29.
GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y et al (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 303(17):1729–1737CrossRef
30.
Murakami T (1971) Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 11:53–55
31.
Kitaoka H, Yoshikawa K, Suzuki M, Yoshida S, Yamagushi H, Hirota T et al (1983) Study on local resection of the tumor with preservation of the regional lymph-nodes for early gastric cancer (in Japanese). Nihon Gan Chiryo Gakkai Shi 18:969–978PubMed
32.
Ohgami M, Otani Y, Kumai K, Kubota T, Kim YI, Kitajima M (1999) Curative laparoscopic surgery for early gastric cancer: five years experience. World J Surg 23:187–192PubMedCrossRef
33.
Sano T, Kobori O, Muto T (1992) Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 79:241–244PubMedCrossRef
34.
Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami N, Fujimura T, Tsujimoto H, Hayashi H, Yoshimizu N, Takagane A, Mohri Y, Nabeshima K, Uenosono Y, Kinami S, Sakamoto J, Morita S, Aikou T, Miwa K, Kitajima M (2013) Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol 31(29):3704–3710PubMedCrossRef
35.
Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ, Bae JM (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248(5):721–727PubMedCrossRef
36.
Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Lee HJ, Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group (2016) Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 263(1):28–35PubMedCrossRef
37.
Lu W, Gao J, Yang J, Zhang Y, Lv W, Mu J, Dong P, Liu Y (2016) Long-term clinical outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for early gastric cancer: a comprehensive systematic review and meta-analysis of randomized control trials. Medicine (Baltimore) 95(27):e3986CrossRef
38.
Deng Y, Zhang Y, Guo TK (2015) Laparoscopy-assisted versus open distal gastrectomy for early gastric cancer: a meta-analysis based on seven randomized controlled trials. Surg Oncol 24(2):71–77PubMedCrossRef
39.
Bozzetti F, Marubini E, Bonfanti G et al (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 230:170PubMedPubMedCentralCrossRef
40.
Gouzi JL, Huguier M, Fagniez PL et al (1989) Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 209:162PubMedPubMedCentralCrossRef
41.
Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123CrossRef
42.
Sugoor P, Shah S, Dusane R, Desouza A, Goel M, Shrikhande SV (2016) Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always necessary. Langenbeck's Arch Surg 401(5):687–697CrossRef
43.
Buhl K, Schlag P, Herfarth C (1990) Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol 16:404PubMed
44.
Pu YW, Gong W, Wu YY et al (2013) Proximal gastrectomy versus total gastrectomy for proximal gastric carcinoma. A meta-analysis on postoperative complications, 5-year survival, and recurrence rate. Saudi Med J 34:1223PubMed
45.
Shen W-S, Xi H-Q, Wei B, Chen L (2014) Effect of gastrectomy with bursectomy on prognosis of gastric cancer: a meta-analysis. World J Gastroenterol 20(40):14986–14991PubMedPubMedCentralCrossRef
46.
Terashima M, Doki Y, Kurokawa Y, Mizusawa J, Katai H, Yoshikawa T, Kimura Y, Takiguchi S, Nishida Y, Iwasaki Y, Fukushima N, Kaji M, Hirao M, Kurita A, Ito S, Yabusaki H, Sano T, Katayama H, Nakamura K, Sasako M, Stomach Cancer Study Group, Japan Clinical Oncology Group (2017) Primary results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). J Clin Oncol 35(4_suppl):5CrossRef
47.
Japanese Gastric Cancer Association (2010) Japanese classification of gastric cancer, 14th edn. Kanehara & Co. Ltd, Tokyo
48.
Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R (2006) D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 23(3):192–197PubMedCrossRef
49.
Bonenkamp J, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345(8952):745–748PubMedCrossRef
50.
Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 347(9007):995–999PubMedCrossRef
51.
Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309–315PubMedCrossRef
52.
Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11:439–449PubMedCrossRef
53.
Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH (2013) Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol 107(8):807–814PubMedCrossRef
54.
Biondi A, D'Ugo D, Cananzi FC, Papa V, Borasi A, Sicoli F, Degiuli M, Doglietto G, Persiani R (2015) Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Eur J Surg Oncol 41(6):779–786PubMedCrossRef
55.
56.
57.
Mine S, Sano T, Hiki N, Yamada K, Kosuga T, Nunobe S, Yamaguchi T (2013) Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 100:1050–1054PubMedCrossRef
58.
Postlewait LM, Squires MH 3rd, Kooby DA et al (2015) The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: a multi-institutional study of the US Gastric Cancer Collaborative. J Surg Oncol 112:203–207PubMedCrossRef
59.
Lee CM, Jee YS, Lee JH et al (2014) Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer. World J Gastroenterol 20:10518–10524PubMedPubMedCentralCrossRef
60.
Braga M, Molinari M, Zuliani W, Foppa L, Gianotti L, Radaelli G, Cristallo M, di Carlo V (1996) Surgical treatment of gastric adenocarcinoma: impact on survival and quality of life. A prospective ten year study. Hepato-Gastroenterology 43:187–193PubMed
61.
Rausei S, Mangano A, Galli F et al (2013) Quality of life after gastrectomy for cancer evaluated via the EORTC QLQ-C30 and QLQ-STO22 questionnaires: surgical considerations from the analysis of 103 patients. Int J Surg 11:S104–S109PubMedCrossRef
62.
Squires MH III, Kooby DA, Poultsides GA et al (2014) Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol 22:1243–1251PubMedCrossRef
63.
Kakeji Y, Tsujitani S, Baba H, Moriguchi S, Mori M, Maehara Y, Kamegawa T, Sugimachi K (1991) Clinicopathologic features and prognostic significance of duodenal invasion in patients with distal gastric carcinoma. Cancer 68:380–384PubMedCrossRef
64.
Bickenbach KA, Gonen M, Strong V, Brennan MF, Coit DG (2013) Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol 20:2663–2668PubMedCrossRef
65.
Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH (2006) Intraoperative frozen section margin evaluation in gastric cancer of the cardia surgery. Hepato-Gastroenterology 53:976–978PubMed
66.
Spicer J, Benay C, Lee L, Rousseau M, Andalib A, Kushner Y, Marcus V, Ferri L (2014) Diagnostic accuracy and utility of intraoperative microscopic margin analysis of gastric and esophageal adenocarcinoma. Ann Surg Oncol 21:2580–2586PubMedCrossRef
67.
Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF (1999) Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 3:24–33PubMedCrossRef
68.
Chen JD, Yang XP, Shen JG, Hu WX, Yuan XM, Wang LB (2013) Prognostic improvement of reexcision for positive resection margins in patients with advanced gastric cancer. Eur J Surg Oncol 39:229–234PubMedCrossRef
69.
Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC (2007) Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute. J Surg Oncol 95:461–468PubMedCrossRef
70.
Nagata T, Ichikawa D, Komatsu S, Inoue K, Shiozaki A, Fujiwara H, Okamoto K, Sakakura C, Otsuji E (2011) Prognostic impact of microscopic positive margin in gastric cancer patients. J Surg Oncol 104:592–597PubMedCrossRef
71.
Roberts P, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N (2012) Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer. Gastric Cancer 15(Suppl 1):S108–S115PubMedCrossRef
72.
Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, Coburn NG (2012) Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer 15(Suppl 1):S100–S107 Epub 2011 Jul 23PubMedCrossRef
73.
Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y et al (2012) Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer 12:526PubMedPubMedCentralCrossRef
74.
Glehen O, Passot G, Villeneuve L, Vaudoyer D, Bin-Dorel S, Boschetti G et al (2014) GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 14:183PubMedPubMedCentralCrossRef
75.
Garofalo A, Valle M, Garcia J, Sugarbaker PH (2006) Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol 32:682–685PubMedCrossRef
76.
Roviello F, Caruso S, Neri A, Marrelli D (2013) Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 39(12):1309–1316
77.
Facchiano E, Scaringi S, Kianmanesh R, Sabate JM, Castel B, Flamant Y, Coffin B, Msika S (2008) Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol 34:154–158PubMedCrossRef
78.
79.
Lee HJ, Shin JH, Yoon HK, Ko GY, Gwon DI, Song HY, Sung KB (2009) Transcatheter arterial embolization in gastric cancer patients with acute bleeding. Eur Radiol 19(4):960–965PubMedCrossRef
80.
Kasakura Y, Ajani JA, Fujii M, Mochizuki F, Takayama T (2002) Management of perforated gastric carcinoma: a report of 16 cases and review of world literature. Am Surg 68(5):434–440PubMed
81.
Lee JA, Lim DH, Park W, Ahn YC, Huh SJ (2009) Radiation therapy for gastric cancer bleeding. Tumori. 95(6):726–730PubMedCrossRef
82.
No JH, Kim SW, Lim CH, Kim JS, Cho YK, Park JM, Lee IS, Choi MG, Choi KY (2013) Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery. Gastrointest Endosc 78(1):55–62PubMedCrossRef
Metadaten
Titel
Surgery for Gastric Cancer: State of the Art
verfasst von
Manish S. Bhandare
Vikram Chaudhari
Shailesh V. Shrikhande
Publikationsdatum
10.02.2020
Verlag
Springer India
Erschienen in
Indian Journal of Surgery / Ausgabe Sonderheft 3/2021
Print ISSN: 0972-2068
Elektronische ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-019-02061-5

Weitere Artikel der Sonderheft 3/2021

Indian Journal of Surgery 3/2021 Zur Ausgabe

Original Article

Risk Factors for Parastomal Hernia Associated with Covering Stoma in Rectal Surgery

Original Article

Pathological Complete Response After Neoadjuvant Therapy in Rectal Adenocarcinoma: a 5-Year Follow-up

Original Article

SELSI Consensus Statement for Safe Cholecystectomy — Prevention and Management of Bile Duct Injury — Part A

Original Article

Surgical Approaches to Oesophageal Carcinoma: Evolution and Evaluation

Surgical Techniques and Innovations

A Novel Technique of Endoscopic Punching Forceps to Remove Inadvertently Sutured Drainage Tube

Original Article

The Surgical Management of Rectal Prolapse

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | HNO-Chirurgie | Nachrichten

HNO-Op. auch mit über 90?
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.